BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34475205)

  • 21. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
    Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells.
    Xu X; Wang L; Hu L; Dirks WG; Zhao Y; Wei Z; Chen D; Li Z; Wang Z; Han Y; Wei L; Drexler HG; Hu Z
    Int J Cancer; 2020 Jan; 146(2):400-412. PubMed ID: 31271662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.
    Ko S; Shi L; Kim S; Song CS; Chatterjee B
    Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JMJD1C Regulates Megakaryopoiesis in In Vitro Models through the Actin Network.
    Wang J; Liu X; Wang H; Qin L; Feng A; Qi D; Wang H; Zhao Y; Kong L; Wang H; Wang L; Hu Z; Xu X
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
    Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
    Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
    Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
    Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines.
    Ramamurthy VP; Ramalingam S; Gediya L; Kwegyir-Afful AK; Njar VC
    Oncotarget; 2015 Feb; 6(5):3195-210. PubMed ID: 25605250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
    Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The histone demethylase JMJD1C regulates CPS1 expression and promotes the proliferation of paroxysmal nocturnal haemoglobinuria clones through cell metabolic reprogramming.
    Chen Y; Liu H; Wang C; Chen W; Li L; Wu J; Wang G; Ling GS; Fu R
    Br J Haematol; 2024 Jun; 204(6):2468-2479. PubMed ID: 38650379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity.
    Schimek V; Björn N; Pellé L; Svedberg A; Gréen H
    Pharmacogenet Genomics; 2021 Apr; 31(3):60-67. PubMed ID: 33075016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting JMJD1C to selectively disrupt tumor T
    Long X; Zhang S; Wang Y; Chen J; Lu Y; Hou H; Lin B; Li X; Shen C; Yang R; Zhu H; Cui R; Cao D; Chen G; Wang D; Chen Y; Zhai S; Zeng Z; Wu S; Lou M; Chen J; Zou J; Zheng M; Qin J; Wang X
    Nat Immunol; 2024 Mar; 25(3):525-536. PubMed ID: 38356061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
    Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
    Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
    Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
    J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer.
    Xu S; Fan L; Jeon HY; Zhang F; Cui X; Mickle MB; Peng G; Hussain A; Fazli L; Gleave ME; Dong X; Qi J
    Cancer Res; 2020 Aug; 80(15):3074-3087. PubMed ID: 32522824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover.
    Coffey K; Rogerson L; Ryan-Munden C; Alkharaif D; Stockley J; Heer R; Sahadevan K; O'Neill D; Jones D; Darby S; Staller P; Mantilla A; Gaughan L; Robson CN
    Nucleic Acids Res; 2013 Apr; 41(8):4433-46. PubMed ID: 23435229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jmjd1c demethylates STAT3 to restrain plasma cell differentiation and rheumatoid arthritis.
    Yin Y; Yang X; Wu S; Ding X; Zhu H; Long X; Wang Y; Zhai S; Chen Y; Che N; Chen J; Wang X
    Nat Immunol; 2022 Sep; 23(9):1342-1354. PubMed ID: 35995859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells.
    Liu W; Wang C; Wang S; Zeng K; Wei S; Sun N; Sun G; Wang M; Zou R; Liu W; Lin L; Song H; Jin Z; Zhao Y
    Int J Biol Sci; 2021; 17(1):188-203. PubMed ID: 33390843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
    Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
    Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.